Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Cremer has pursued his PhD from Witwatersrand University, South Africa and post-doctoral studies form McGill University, USA. He is currently working as an associate professor in division of infectious diseases, University of Pittburg, USA. Dr Sluis-Cremer's research focuses on antiretroviral drugs, drug resistance and HIV latency. Projects include understanding the biochemistry and cellular biology of HIV reverse transcription, elucidating the mechanisms of action and resistance to HIV antiviral drugs, and the discovery of novel inhibitors active against drug resistant HIV-1. New initiatives include understanding the mechanisms involved in HIV latency and pharmacological approaches to eradicate latent HIV infection.
HIV, AIDS, STDs, Antimicrobials, Treatment and Diagnosis, vaccines.
Jenn Zerbato and Nicolas Sluis-Cremer
Editorial: J Antivir Antiretrovir 2013, S10: e001